Revolade
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Revolade |
|---|---|
| Active Substance | eltrombopagolamin |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| ATC Code | B02BX05 |
| Medicinal product marketed in the Croatia | Da |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
| Educational materials for healthcare professionals |
cITP Vodič za zdravstvene radnike, verzija 2 cITP Vodič za sigurnu primjenu lijeka, verzija 2 |
| Educational materials for patients / caregivers |
cITP vodič za bolesnike, verzija 1 |
